The medicine shortage reports database includes information about shortages of reportable medicines in Australia, including those arising from the discontinuation of products.
You can use this page to search for all medicines in shortage and find information about management actions, including supply of overseas alternative medicines.
Information in this database is based on details reported to us by sponsors. Any additional management actions taken by us will be clearly stated.
How to search
The database defaults to all current medicine shortages. You can also view anticipated and resolved shortages and discontinuations.
To search the database for all shortages and discontinuations for a particular medicine, type the active ingredient or trade (brand) name into the search field. You can then click on the active ingredient name or trade name for more information about the shortage of interest.
You can also download an extract of all shortages and discontinuations.
To view all medicines shortages and discontinuations with a critical shortage impact rating, click on the CRITICAL medicine shortages link below.
Further information
Information about medicine shortages is available at the Medicine Shortages hub
Subscribe to Medicine Shortages updates
You can subscribe to Medicine Shortages Email Alerts or the Medicine Shortages RSS feed for frequently updated information.
This service does not support Internet Explorer 7 and below.
Search Results
Browse CRITICAL shortages and discontinuations
Click here to display ALL medicine shortages and discontinuations
AUST R: 14332
Expected supply: 31 Dec 2026
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. Please contact the approval holder for details on supply: Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific - Ph: 02 9503 8100
Updated: 02-01-2024
phenoxybenzamine hydrochloride
AUST R: 12980
Expected supply: 30 Jun 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
Updated: 07-05-2024
AUST R: 161298
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
AUST R: 18695
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
AUST R: 18770
Expected supply: 31 May 2025
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 29-03-2023
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)
ONCOTICE BCG 5 hundred million CFU powder for injection vial
AUST R: 59912
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 07-03-2022
CIPLA BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial
AUST R: 220440
Expected supply: 31 Mar 2024
Availability: Unavailable
Management action: An alternative brand is available
Updated: 03-10-2023
SYNACTHEN DEPOT tetracosactide (tetracosactrin) zinc complex 1mg/1m L injection ampoule
AUST R: 11060
Expected supply: 30 Nov 2026
Availability: Unavailable
Updated: 31-10-2023
HYDRALAZINE LINK hydralazine hydrochloride 20 mg/1 mL solution for injection vial
AUST R: 272644
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative brand available
Updated: 28-03-2023
AUST R: 235933
Expected supply: 15 Aug 2024
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 25-06-2024
CARBOSORB XS activated charcoal 50 g/250 mL and sorbitol 70.75 g/250 mL suspension bottle
AUST R: 307429
Expected supply: 11 Jun 2024
Availability: Available
Updated: 11-06-2024
adrenaline (epinephrine) acid tartrate
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Other strengths available.
Updated: 05-04-2024
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack
AUST R: 60673
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient
Updated: 09-02-2024
AUST R: 81930
Expected supply: 31 Dec 2024
Availability: Unavailable
Updated: 19-04-2024
AUST R: 81931
Expected supply: 31 Dec 2024
Availability: Unavailable
Updated: 19-04-2024
METALYSE tenecteplase (rch) 50mg powder for injection vial plus prefilled syringe
AUST R: 75013
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: A TGA web statement is available at https://www.tga.gov.au/alert/shortage-tenecteplase-metalyse. The TGA has approved a shelf-life extension of an additional 12 months from the original expiry date on the packaging for Metalyse batches with an original expiry date from January 2022 up to March 2025.
Unregistered alternative products have been approved for supply under Section 19A. For information on supply, contact the approval holders: Pro Pharmaceuticals Group Pty Ltd (Phone: 1300 077 674) or Medsurge Healthcare Pty Ltd (Phone: 1300 788 261).
Updated: 17-08-2023
ACTILYSE alteplase (rch) 50 mg powder for injection vial with diluent vial
AUST R: 17905
Expected supply: 31 Dec 2024
Availability: Limited Availability
Updated: 19-10-2023
ACTILYSE alteplase (rch) 10mg powder for injection vial with water for injections 10mL vial
AUST R: 64240
Expected supply: 31 Dec 2024
Availability: Limited Availability
Updated: 19-10-2023
MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial
AUST R: 316671
Expected supply: 26 Dec 2022
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 03-11-2022
HEPARIN SODIUM 5000IU/5mL (porcine mucous) injection ampoule
AUST R: 49232
Expected supply: 30 Sep 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.
Updated: 11-06-2024
suxamethonium chloride dihydrate
SUXAMETHONIUM JUNO suxamethonium chloride dihydrate 100 mg/2 mL injection ampoule
AUST R: 320687
Expected supply: 26 Apr 2024
Availability: Available
Updated: 30-04-2024
AUST R: 144970
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Other brands are available.
Updated: 11-08-2023
AUST R: 276671
Expected supply: 14 May 2024
Availability: Available
Updated: 20-05-2024
Updated: 09-05-2024
PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial
AUST R: 10509
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An imipenem/cilastatin injection product may be available via the Special Access Scheme (SAS): https://www.tga.gov.au/products/prescribe-unapproved-therapeutic-good-health-practitioners
Updated: 30-04-2024
DBL Aciclovir 500mg/20mL Intravenous infusion injection vial
AUST R: 56810
Expected supply: 08 Jul 2024
Availability: Available
Updated: 08-07-2024
AUST R: 49945
Expected supply: 25 Jun 2024
Availability: Available
Updated: 25-06-2024
IBIMICYN ampicillin 1g (as sodium) powder for injection vial
AUST R: 92840
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 27-09-2023
DBL Aciclovir 250mg/10mL Intravenous infusion injection vial
AUST R: 56809
Expected supply: 10 Jan 2025
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group Pty Ltd, can be contacted for details on supply on 1300 077 674.
Updated: 19-05-2024
AMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vial
AUST R: 288798
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Alternative generic product is available.
Updated: 30-05-2024
AUST R: 94175
Expected supply: 31 Jan 2025
Availability: Unavailable
Updated: 24-05-2024
AUST R: 101243
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available and other strengths are available.
Updated: 27-09-2023
AUST R: 233443
Expected supply: 30 Apr 2024
Availability: Available
Updated: 30-04-2024
VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial
AUST R: 267013
Expected supply: 31 Dec 2024
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 28-05-2024
AUST R: 61887
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Other strengths are available
Updated: 02-02-2024
AUST R: 16290
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative brand is available.
Updated: 27-10-2023
DBL LEUCOVORIN CALCIUM folinic acid 50 mg/5 mL (as calcium folinate) injection USP vial (NF)
AUST R: 42148
Expected supply: 17 May 2024
Availability: Available
Updated: 17-05-2024
AUST R: 48230
Expected supply: 09 Aug 2024
Availability: Unavailable
Management action: An alternative generic product is available.
Updated: 24-07-2024
AUST R: 159338
Expected supply: 31 Aug 2024
Availability: Unavailable
Updated: 06-05-2024
AUST R: 159342
Expected supply: 31 Jul 2024
Availability: Unavailable
Updated: 02-05-2024
TECHNESCAN HDP kit for preparation of Technetium [99mTc] oxidronate powder for injection vial
AUST R: 75500
Expected supply: 01 Jul 2024
Availability: Unavailable
Management action: Unregistered products have been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.
Updated: 18-07-2024
BRINEURA cerliponase alfa (rch) 150 mg/5 mL solution for injection vial with flushing solution vial
AUST R: 298672
Expected supply: 18 Nov 2024
Availability: Available
Management action: The sponsor is working to expedite the next shipment.
Updated: 14-06-2024
AUST R: 18845
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: The sponsor is closely controlling the supply. The TGA is working to develop a management strategy.
Updated: 01-06-2024
ISOPRENALINE MACURE isoprenaline hydrochloride 1 mg/5 mL solution for injection ampoule
AUST R: 370377
Expected supply: 27 Jun 2025
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 28-06-2024
AUST R: 77283
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: An alternative unapproved product may be available under the Special Access Scheme (SAS). For further information about SAS please see https://www.tga.gov.au/form/special-access-scheme
Updated: 07-03-2024
naloxone hydrochloride dihydrate
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
AUST R: 309381
Expected supply: 29 Apr 2024
Availability: Available
Updated: 29-04-2024
PARACETAMOL KABI paracetamol 1000mg/100mL solution for injection vial
AUST R: 203624
Expected supply: 02 Sep 2024
Availability: Limited Availability
Management action: Unregistered products have been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 02-05-2024
AUST R: 14328
Expected supply: 16 Jul 2024
Availability: Available
Updated: 22-07-2024
AUST R: 48231
Expected supply: 26 Jun 2024
Availability: Available
Updated: 26-06-2024
AUST R: 389746
Expected supply: 30 Apr 2024
Availability: Available
Updated: 17-05-2024
AUST R: 13455
Expected supply: 30 Aug 2024
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 11-06-2024
Pfizer (Australia) DAUNORUBICIN (as hydrochloride) 20mg/10mL injection vial
AUST R: 12723
Expected supply: 17 May 2024
Availability: Available
Updated: 17-05-2024
Pfizer (Australia) GENTAMICIN 80mg/2mL (as sulfate) injection BP ampoule
AUST R: 11376
Expected supply: 31 Mar 2025
Availability: Available
Management action: The sponsor is working to expedite the next shipment. An alternative generic product is available.
Updated: 14-05-2024
EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial
AUST R: 346216
Expected supply: 16 May 2024
Availability: Available
Updated: 22-05-2024
dexamethasone sodium phosphate
DBL DEXAMETHASONE SODIUM PHOSPHATE INJECTION 8mg/2mL (as sodium) injection vial
AUST R: 178774
Expected supply: 31 Dec 2024
Availability: Limited Availability
Management action: Alternative generic products are available.
Updated: 09-07-2024
AUST R: 313546
Expected supply: 01 Oct 2024
Availability: Unavailable
Management action: The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. The approval holder, Pro Pharmaceuticals Group Pty Ltd, can be contacted for details on supply on 1300 077 674.
Updated: 25-07-2024
AUST R: 12514
Expected supply: 17 Jun 2024
Availability: Available
Updated: 18-06-2024
AUST R: 60049
Expected supply: 29 Nov 2024
Availability: Limited Availability
Management action: An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
Updated: 31-05-2024
ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule
AUST R: 195796
Expected supply: 13 May 2024
Availability: Available
Updated: 13-05-2024
AUST R: 46451
Expected supply: 16 Jul 2024
Availability: Available
Updated: 17-07-2024
ALLMERCAP mercaptopurine monohydrate 20mg/mL oral liquid suspension bottle
AUST R: 213881
Expected supply: 17 May 2024
Availability: Available
Updated: 20-05-2024
AUST R: 16377
Expected supply: 10 Jul 2024
Availability: Available
Updated: 10-07-2024
cefepime hydrochloride monohydrate
CEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
AUST R: 227965
Expected supply: 31 Dec 2024
Availability: Available
Management action: An alternative brand is available.
Updated: 25-07-2024
AUST R: 61885
Expected supply: Unknown
Availability: Unavailable
Management action: Alternative generic products are available
Updated: 09-05-2024
CYMEVENE ganciclovir 500mg (as sodium) powder for injection vial
AUST R: 10047
Expected supply: 04 Jul 2024
Availability: Available
Updated: 08-07-2024
cefepime hydrochloride monohydrate
AUST R: 196280
Expected supply: 28 May 2024
Availability: Available
Updated: 29-05-2024
CLEXANE enoxaparin sodium 60mg/0.6mL injection syringe with automatic safety lock system
AUST R: 221719
Expected supply: 12 Jun 2024
Availability: Available
Updated: 12-06-2024
AUST R: 53160
Expected supply: 17 Jun 2024
Availability: Available
Updated: 17-06-2024
3% CITANEST DENTAL WITH OCTAPRESSIN 2.2mL injection cartridge
AUST R: 220320
Expected supply: 16 Aug 2024
Availability: Unavailable
Management action: The sponsor is closely controlling the supply.
Updated: 20-06-2024
noradrenaline (norepinephrine) acid tartrate monohydrate
Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial
AUST R: 183622
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic products are available.
Updated: 23-05-2024
DBL LEUCOVORIN CALCIUM folinic acid 300 mg/30 mL (as calcium folinate) injection vial
AUST R: 116688
Expected supply: 13 Sep 2024
Availability: Available
Management action: The sponsor is closely controlling the supply and working to expedite the next shipment.
Updated: 09-07-2024
ACICLOVIR VIATRIS aciclovir (as sodium) 250 mg powder for injection vial
AUST R: 233649
Expected supply: 09 Jul 2024
Availability: Available
Updated: 09-07-2024
AUST R: 100517
Expected supply: 31 Jul 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 04-06-2024
Q-VAX SKIN TEST (Inactivated C. burnetii for Pre-Q-Vax Vaccination Screening) injection vial
AUST R: 100518
Expected supply: 31 Jul 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply
Updated: 04-06-2024
AUST R: 54638
Expected supply: 30 Aug 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 08-07-2024
JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial
AUST R: 352631
Expected supply: 30 Aug 2024
Availability: Limited Availability
Management action: Sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.
Updated: 18-07-2024
ACICLOVIR VIATRIS aciclovir (as sodium) 500 mg powder for injection vial
AUST R: 233648
Expected supply: 09 Jul 2024
Availability: Available
Updated: 09-07-2024
hydrocortisone sodium succinate
AUST R: 167893
Expected supply: 04 Oct 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 24-07-2024
AUST R: 15417
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Product will be replaced by METHOBLASTIN methotrexate (as sodium) 10 mg tablet blister pack ARTG 410933.
Updated: 18-06-2024
AUST R: 40624
Expected supply: 15 Jul 2024
Availability: Unavailable
Management action: Sponsor is working to expedite the next shipment.
Updated: 21-06-2024
hydrocortisone sodium succinate
AUST R: 167894
Expected supply: 04 Oct 2024
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 25-07-2024
adrenaline (epinephrine) acid tartrate
AUST R: 282377
Expected supply: 15 Aug 2024
Availability: Unavailable
Management action: Alternative generic products are available.
Updated: 18-07-2024
KONAKION MM PAEDIATRIC phytomenadione 2 mg/0.2 mL injection ampoule
AUST R: 71758
Expected supply: 16 Aug 2024
Availability: Limited Availability
Management action: The sponsor is working to expedite the next shipment and closely controlling the supply.
An unregistered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
Updated: 18-07-2024
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen
AUST R: 170446
Expected supply: 30 Jun 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 25-07-2024
BOSENTAN RBX bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack
AUST R: 257757
Expected supply: 16 Aug 2024
Availability: Unavailable
Management action: Alternative generic product is available.
Updated: 01-07-2024
AUST R: 337517
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
AUST R: 337512
Expected supply: Unknown
Availability: Reduction in supply until supply is exhausted
Management action: Alternative generic product is available.
Updated: 12-07-2024
magnesium chloride hexahydrate
EXTRANEAL 7.5% w/v icodextrin peritoneal dialysis solution bag AHB5546
AUST R: 91344
Expected supply: 30 Jun 2025
Availability: Limited Availability
Management action: The sponsor is closely controlling the supply.
Updated: 17-07-2024
{{headingLabels[selectedTab]}}
Sort by: Updated date | Active ingredient | Trade name | Therapeutic class
URL: http://apps.tga.gov.au/prod/MSI/search/